A multicenter phase 3 trial comparing ocrelizumab to fingolimod for children with MS achieved its noninferiority primary ...
News-Medical.Net on MSN
Ocrelizumab provides superior control of multiple sclerosis relapses compared to other therapies
New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...
Treatment with Sanofi's frexalimab was seen in a study to safely maintain disease control over 2.5 years in adults with ...
The majority of infections in multiple sclerosis (MS) are reported in non-neurology practices, according to study results presented at the European Committee for Treatment and Research in Multiple ...
In this article, ACRO explores multiple sclerosis—a silent battle unfolding within the central nervous system.
Everyday Health on MSN
6 Frequently Asked Questions About Inactive Secondary-Progressive MS, Answered
Having inactive secondary progressive multiple sclerosis can be confusing. Relapses may stop, but symptoms persist. Get ...
Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback